 NEW YORK and LONDON and IRVINE, Calif. and BASEL, Switzerland, Nov. 12, 2020 PRNewswire -- Sumitovant Biopharma and Urovant Sciences Nasdaq: UROV today announced that they have entered into a definitive merger agreement for Sumitovant to acquire the outstanding shares of Urovant... 